Summary
- Current Price
- As of today, RLYB price is $9.96, down -0.45% in the most recent trading session on
- Current Price All-Time High
- RLYB price is currently -95.17% below its historical high of $206.24 set on
- Market Cap
- RLYB current market cap is $421M, up +1392.78% over the past 365 days
- PE Ratio
- RLYB PE ratio is unknown
- Revenue
- RLYB current annual revenue is $636.00K, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for RLYB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Rallybio Corporation |
| Ticker | NASDAQ: RLYB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rallybio.com |
| Employees | 24 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $9.96 | ||
| Price, 1D Change | -0.45% | |
| $421M | ||
| - | ||
| - | ||
| 1.06 | ||
| $636K | ||
| Revenue, 1Y Change | +100.00% | |
| -$10.61 | ||
| EPS, 1Y Change | -475.77% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:8 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$10.61 | ||
| EPS Estimate | N/A | -$1.80 |
| EPS Est. Change | N/A | +83.04% |
| $636.00K | ||
| Revenue Estimate | N/A | $733.33K |
| Revenue Est. Change | N/A | +15.30% |
| $9.96 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.80 | -$1.84 | -2.42% | |
| -$1.45 | -$10.61 | -634.55% | |
| -$1.80 | N/A | +83.04% | |
| -$5.40 | N/A | +49.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $674.50K | $636.00K | -5.71% | |
| $733.33K | N/A | +15.30% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +83.81% | ||
| -76.39% | ||
| +1,392.78% | ||
| +109.58% | ||
| +100.00% | ||
| +100.00% | ||
| -475.77% | ||
| -625.42% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $9.96 | ||
| $4.75 | ||
| SMA 200 vs Price | -52.27% | |
| $6.07 | ||
| SMA 50 vs Price | -39.02% | |
| 1.06 | ||
| $0.85 | ||
| 71.75 | ||
| 244.24% | ||
| 119.05% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $636.00K | ||
| -$10.61 | ||
| $505.00K | ||
| 79.40% | ||
| -$60.50M | ||
| -9,511.95% | ||
| -$57.78M | ||
| -9,084.12% | ||
| -$60.37M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 10.87 | ||
| 10.87 | ||
| - | ||
| 1 | ||
| 31.24 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 623.94 | ||
| 6.67 | ||
| -10.40 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $61.65M | ||
| $13.90M | ||
| $68.11M | ||
| $67.84M | ||
| $6.45M | ||
| $6.24M | ||
| $154.00K | ||
| $154.00K | ||
| $278.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $58.41M | ||
| $61.00M | ||
| $131.00K | ||
| $19.63M | ||
| $131.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$49.28M | ||
| $33.49M | ||
| $5.20M | ||
| $0.00 | ||
| -$49.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jones Trading | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RLYB
FAQ
What is the ticker symbol for Rallybio Corporation?
The ticker symbol for Rallybio Corporation is NASDAQ:RLYB
Does Rallybio Corporation pay dividends?
No, Rallybio Corporation does not pay dividends
What sector is Rallybio Corporation in?
Rallybio Corporation is in the Healthcare sector
What industry is Rallybio Corporation in?
Rallybio Corporation is in the Biotechnology industry
What country is Rallybio Corporation based in?
Rallybio Corporation is headquartered in United States
When did Rallybio Corporation go public?
Rallybio Corporation initial public offering (IPO) was on July 29, 2021
Is Rallybio Corporation in the S&P 500?
No, Rallybio Corporation is not included in the S&P 500 index
Is Rallybio Corporation in the NASDAQ 100?
No, Rallybio Corporation is not included in the NASDAQ 100 index
Is Rallybio Corporation in the Dow Jones?
No, Rallybio Corporation is not included in the Dow Jones index
When was Rallybio Corporation last earnings report?
Rallybio Corporation's most recent earnings report was on August 7, 2025
When does Rallybio Corporation report earnings?
The date for Rallybio Corporation's next earnings report has not been announced yet
Data Sources & References
- RLYB Official Website www.rallybio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1739410/000173941025000040/0001739410-25-000040-index.htm
- RLYB Profile on Yahoo Finance finance.yahoo.com/quote/RLYB
- RLYB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlyb